The gut microbiome and cancer response to immune checkpoint inhibitors
Rivista: The Journal of Clinical Investigation Autori: Francesca S. Gazzaniga1 and Dennis L. Kasper2 1 Department of Pathology and Krantz Family Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. 2 Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, USA.
